Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56


Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?

Njoroge J, Hope VD, O'Halloran C, Edmundson C, Glass R, Parry JV, Ncube F.

Epidemiol Infect. 2019 Jan;147:e244. doi: 10.1017/S0950268819001353.


Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey.

Hibbert MP, Porcellato LA, Brett CE, Hope VD.

Int J Drug Policy. 2019 Jul 26. pii: S0955-3959(19)30220-8. doi: 10.1016/j.drugpo.2019.07.034. [Epub ahead of print]


Psychosocial and sexual characteristics associated with sexualised drug use and chemsex among men who have sex with men (MSM) in the UK.

Hibbert MP, Brett CE, Porcellato LA, Hope VD.

Sex Transm Infect. 2019 Aug;95(5):342-350. doi: 10.1136/sextrans-2018-053933. Epub 2019 Apr 12.


Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.

Glass R, Hope VD, Njoroge J, Edmundson C, Smith J, McVeigh J, Parry J, Desai M.

Drug Alcohol Depend. 2019 Feb 1;195:40-44. doi: 10.1016/j.drugalcdep.2018.11.021. Epub 2018 Dec 14.


A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.

Hope VD, Harris RJ, Vickerman P, Platt L, Shute J, Cullen KJ, Ijaz S, Mandal S, Ncube F, Desai M, Parry JV.

Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1700635.


Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P.

Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.


Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

Ward Z, Platt L, Sweeney S, Hope VD, Maher L, Hutchinson S, Palmateer N, Smith J, Craine N, Taylor A, Martin N, Ayres R, Dillon J, Hickman M, Vickerman P.

Addiction. 2018 May 17. doi: 10.1111/add.14217. [Epub ahead of print]


'Slamming' among men who have sex with men accessing general drug services, in response to Schmidt, AJ et al., 2016, Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS).

Glass R, Hope VD, Tanner C, Desai M.

Int J Drug Policy. 2017 Nov;49:24-25. doi: 10.1016/j.drugpo.2017.07.028. Epub 2017 Sep 3. No abstract available.


Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15.

Hope VD, McVeigh J, Smith J, Glass R, Njoroge J, Tanner C, Parry JV, Ncube F, Desai M.

Drug Alcohol Depend. 2017 Oct 1;179:83-86. doi: 10.1016/j.drugalcdep.2017.06.018. Epub 2017 Jul 18.


Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.

Hope VD, Iversen J, Cullen KJ, Parry JV, Maher L, Nucbe F.

Int J Drug Policy. 2017 Aug;46:28-33. doi: 10.1016/j.drugpo.2017.05.005. Epub 2017 Jun 3.


Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection?

Hope VD, Cullen KJ, Smith J, Jessop L, Parry J, Ncube F.

Euro Surveill. 2016 May 12;21(19). doi: 10.2807/1560-7917.ES.2016.21.19.30225.


Access to needle and syringe programs by people who inject image and performance enhancing drugs.

Iversen J, Hope VD, McVeigh J.

Int J Drug Policy. 2016 May;31:199-200. doi: 10.1016/j.drugpo.2016.01.016. Epub 2016 Feb 1. No abstract available.


Harm reduction interventions should encompass people who inject image and performance enhancing drugs.

McVeigh J, Kimergård A, Bates G, Hope VD, Ncube F.

BMJ. 2016 Apr 5;353:i1889. doi: 10.1136/bmj.i1889. No abstract available.


An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.

Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J, Weaver T, Strang J.

Addiction. 2016 Sep;111(9):1616-27. doi: 10.1111/add.13385. Epub 2016 May 6.


Not in the vein: 'missed hits', subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom.

Hope VD, Parry JV, Ncube F, Hickman M.

Int J Drug Policy. 2016 Feb;28:83-90. doi: 10.1016/j.drugpo.2015.11.003. Epub 2015 Nov 17.


Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.

Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, Ncube F.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):331-7. doi: 10.1097/QAI.0000000000000835.


Going into the groin: Injection into the femoral vein among people who inject drugs in three urban areas of England.

Hope VD, Scott J, Cullen KJ, Parry JV, Ncube F, Hickman M.

Drug Alcohol Depend. 2015 Jul 1;152:239-45. doi: 10.1016/j.drugalcdep.2015.03.029. Epub 2015 Apr 9.


Hepatitis B vaccination for people who inject drugs.

Hope VD, Mandal S, Cullen KJ, Balogun K, Ncube F.

Lancet. 2015 Jan 10;385(9963):115-6. doi: 10.1016/S0140-6736(15)60020-4. No abstract available.


Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours.

Croxford S, Platt L, Hope VD, Cullen KJ, Parry JV, Ncube F.

Int J Drug Policy. 2015 Apr;26(4):429-33. doi: 10.1016/j.drugpo.2014.09.014. Epub 2014 Oct 5. No abstract available.


Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.

Cullen KJ, Hope VD, Croxford S, Shute J, Ncube F, Parry JV.

Epidemiol Infect. 2015 May;143(7):1398-407. doi: 10.1017/S0950268814002040. Epub 2014 Aug 14.


Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ; EMCDDA DRID group, Hatzakis A, Prins M, Vickerman P, Lazarus JV, Hope VD, Matheï C.

PLoS One. 2014 Jul 28;9(7):e103345. doi: 10.1371/journal.pone.0103345. eCollection 2014. Review.


Factors associated with the use of cleaned needles and syringes among people who inject drugs in the UK: who should we target to minimise the risks?

Hope VD, Cullen KJ, Croxford S, Parry JV, Ncube F.

Int J Drug Policy. 2014 Sep;25(5):924-7. doi: 10.1016/j.drugpo.2014.02.008. Epub 2014 Feb 28. No abstract available.


Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011.

Hope VD, Harris RJ, De Angelis D, Croxford S, Marongiu A, Parry JV, Ncube F.

Euro Surveill. 2014 Apr 10;19(14). pii: 20762.


Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergård A, Parry JV, Ncube F.

Epidemiol Infect. 2015 Jan;143(1):132-40. doi: 10.1017/S0950268814000727. Epub 2014 Apr 8.


Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England.

Hope VD, Ncube F, Parry JV, Hickman M.

Epidemiol Infect. 2015 Jan;143(1):120-31. doi: 10.1017/S0950268814000284. Epub 2014 Feb 24.


Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities.

Hope VD, Hickman M, Parry JV, Ncube F.

Int J Drug Policy. 2014 Mar;25(2):303-7. doi: 10.1016/j.drugpo.2013.11.012. Epub 2013 Dec 1.


Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.

Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergård A, Croxford S, Beynon CM, Parry JV, Bellis MA, Ncube F.

BMJ Open. 2013 Sep 12;3(9):e003207. doi: 10.1136/bmjopen-2013-003207.


Infections with spore-forming bacteria in persons who inject drugs, 2000-2009.

Palmateer NE, Hope VD, Roy K, Marongiu A, White JM, Grant KA, Ramsay CN, Goldberg DJ, Ncube F.

Emerg Infect Dis. 2013 Jan;19(1):29-34. doi: 10.3201/eid1901.120044.


Modelling HIV in the injecting drug user population and the male homosexual population in a developed country context.

Sutton AJ, House T, Hope VD, Ncube F, Wiessing L, Kretzschmar M.

Epidemics. 2012 Mar;4(1):48-56. doi: 10.1016/j.epidem.2011.12.001. Epub 2012 Jan 6.


A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation.

Hope VD, Palmateer N, Wiessing L, Marongiu A, White J, Ncube F, Goldberg D.

Am J Public Health. 2012 Jan;102(1):122-5. doi: 10.2105/AJPH.2011.300314. Epub 2011 Nov 28.


Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services.

Harris RJ, Hope VD, Morongiu A, Hickman M, Ncube F, DE Angelis D.

Epidemiol Infect. 2012 Jun;140(6):1054-63. doi: 10.1017/S0950268811001634. Epub 2011 Aug 30.


Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.

Harris RJ, Ramsay M, Hope VD, Brant L, Hickman M, Foster GR, De Angelis D.

Eur J Public Health. 2012 Apr;22(2):187-92. doi: 10.1093/eurpub/ckr083. Epub 2011 Jun 26.


Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.

Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV.

J Viral Hepat. 2011 Apr;18(4):262-70. doi: 10.1111/j.1365-2893.2010.01297.x.


The extent of injection site infection in injecting drug users: findings from a national surveillance study.

Hope VD, Marongiu A, Parry JV, Ncube F.

Epidemiol Infect. 2010 Oct;138(10):1510-8. doi: 10.1017/S0950268810000324. Epub 2010 Feb 18.


Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again?

Sweeting MJ, Hope VD, Hickman M, Parry JV, Ncube F, Ramsay ME, De Angelis D.

Am J Epidemiol. 2009 Aug 1;170(3):352-60. doi: 10.1093/aje/kwp141. Epub 2009 Jun 22.


A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.

Sutton AJ, Hope VD, Mathei C, Mravcik V, Sebakova H, Vallejo F, Suligoi B, Brugal MT, Ncube F, Wiessing L, Kretzschmar M.

J Viral Hepat. 2008 Nov;15(11):809-16. doi: 10.1111/j.1365-2893.2008.01041.x. Epub 2008 Aug 28.


Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?

Judd A, Hickman M, Hope VD, Sutton AJ, Stimson GV, Ramsay ME, Gill ON, Parry JV.

J Viral Hepat. 2007 Aug;14(8):584-91.


Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.

Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.

BMC Infect Dis. 2006 Jun 8;6:93.


Modelling the hepatitis B vaccination programme in prisons.

Sutton AJ, Gay NJ, Edmunds WJ, Andrews NJ, Hope VD, Gilbert RL, Piper M, Gill ON.

Epidemiol Infect. 2006 Apr;134(2):231-42.


Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?

Brown AE, Tomkins SE, Logan LE, Lamontagne DS, Munro HL, Hope VD, Righarts A, Blackham JE, Rice BD, Chadborn TR, Tookey PA, Parry JV, Delpech V, Gill ON, Fenton KA.

Sex Transm Infect. 2006 Feb;82(1):4-10.


HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years.

Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, Gill ON.

AIDS. 2005 Jul 22;19(11):1207-14.


Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales.

Craine N, Walker AM, Williamson S, Brown A, Hope VD.

Commun Dis Public Health. 2004 Sep;7(3):216-9.


Sustained increase in the sharing of needles and syringes among drug users in England and Wales.

Hope VD, Rogers PA, Jordan L, Paine TC, Barnett S, Parry JV, Gill ON.

AIDS. 2002 Dec 6;16(18):2494-6. No abstract available.


Failure to vaccinate current injecting drug users against hepatitis B in England and Wales.

Lamagni TL, Hope VD, Davison KL, Parry JV, Gill ON.

Commun Dis Public Health. 2001 Mar;4(1):71-2. Erratum in: Commun Dis Public Health 2002 Jun;5(2):176.


Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Hope VD, Judd A, Hickman M, Lamagni T, Hunter G, Stimson GV, Jones S, Donovan L, Parry JV, Gill ON.

Am J Public Health. 2001 Jan;91(1):38-42.


Relation between information and advice provision to male GUM clinic attendees and sexual orientation and ethnic group.

Hope VD, MacArthur C, Mullis D, Radcliffe K.

Sex Transm Infect. 2000 Jun;76(3):198-202.

Supplemental Content

Support Center